Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo

Journal of Nutritional Biochemistry

Volumn 46, Issue , 2017, Pages 68-73

  Yan, Yuan ^a,b   Liu, Na ^a   Hou, Ni ^a   Dong, Lei ^a   Li, Jie ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Child's Hospital   (China)

Author keywords

Chemoprevention; Chlorogenic acid; ERK; Hepatocellular carcinoma; MMP

Indexed keywords

CHLOROGENIC ACID; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ANTINEOPLASTIC AGENT; MAPK1 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME INACTIVATION; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; DRUG SCREENING; ENZYME ACTIVATION; LIVER TUMOR; METABOLISM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHLOROGENIC ACID; ENZYME ACTIVATION; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85018876916     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2017.04.007     Document Type: Article

References (26)

1. [1] Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics. CA Cancer J Clin 61 (2011), 69–90.
2. [2] Belghiti, J., Panis, Y., Farges, O., Benhamou, J.P., Fekete, F., Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214 (1991), 114–117.
3. [3] Shimizu, M., Shirakami, Y., Sakai, H., Kubota, M., Kochi, T., Ideta, T., et al. Chemopreventive potential of green tea Catechins in hepatocellular carcinoma. Int J Mol Sci 16 (2015), 6124–6139.
4. [4] Yun, N., Kang, J.W., Lee, S.M., Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. J Nutr Biochem 23 (2012), 1249–1255.
5. [5] Zhao, Y., Wang, J., Ballevre, O., Luo, H., Zhang, W., Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res 35 (2012), 370–374.
6. [6] Shi, H., Dong, L., Dang, X., Liu, Y., Jiang, J., Wang, Y., et al. Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells. Inflamm Res 62 (2013), 581–587.
7. [7] Xu, Y., Chen, J., Yu, X., Tao, W., Jiang, F., Yin, Z., et al. Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice. Inflamm Res 59 (2010), 871–877.
8. [8] Ji, L., Jiang, P., Lu, B., Sheng, Y., Wang, X., Wang, Z., Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism. J Nutr Biochem 24 (2013), 1911–1919.
9. [9] Shi, H., Dong, L., Bai, Y., Zhao, J., Zhang, Y., Zhang, L., Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol 623 (2009), 119–124.
10. [10] Arab, L., Epidemiologic evidence on coffee and cancer. Nutr Cancer 62 (2010), 271–283.
11. [11] Inoue, M., Kurahashi, N., Iwasaki, M., Shimazu, T., Tanaka, Y., Mizokami, M., et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 18 (2009), 1746–1753.
12. [12] Ohfuji, S., Fukushima, W., Tanaka, T., Habu, D., Tamori, A., Sakaguchi, H., et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 36 (2006), 201–208.
13. [13] Shi, H., Dong, L., Jiang, J., Zhao, J., Zhao, G., Dang, X., et al. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 303 (2013), 107–114.
14. [14] Yan, Y., Li, J., Han, J., Hou, N., Song, Y., Dong, L., Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases. Anticancer Drugs 26 (2015), 540–546.
15. [15] Yedjou, C.G., Tchounwou, P.B., N-acetyl-l-cysteine affords protection against lead-induced cytotoxicity and oxidative stress in human liver carcinoma (HepG2) cells. Int J Environ Res Public Health 4 (2007), 132–137.
16. [16] Tripathi, D.N., Jena, G.B., Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat Res 696 (2010), 69–80.
17. [17] Wu, C., Luan, H., Zhang, X., Wang, S., Zhang, X., Sun, X., et al. Chlorogenic acid protects against atherosclerosis in ApoE−/− mice and promotes cholesterol efflux from RAW264.7 macrophages. PLoS One, 9, 2014, e95452.
18. [18] Fassina, G., Ferrari, N., Brigati, C., Benelli, R., Santi, L., Noonan, D.M., et al. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis 18 (2000), 111–120.
19. [19] Feng, R., Lu, Y., Bowman, L.L., Qian, Y., Castranova, V., Ding, M., Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280 (2005), 27888–27895.
20. [20] Wang, Q., Chen, Q., He, M., Mir, P., Su, J., Yang, Q., Inhibitory effect of antioxidant extracts from various potatoes on the proliferation of human colon and liver cancer cells. Nutr Cancer 63 (2011), 1044–1052.
21. [21] Intisar, A., Zhang, L., Luo, H., Kiazolu, J.B., Zhang, R., Zhang, W., Anticancer constituents and cytotoxic activity of methanol-water extract of Polygonum bistorta L. Afr J Tradit Complement Altern Med 10 (2012), 53–59.
22. [22] Mannello, F., Tonti, G., Papa, S., Matrix metalloproteinase inhibitors as anticancer therapeutics. Curr Cancer Drug Targets 5 (2005), 285–298.
23. [23] Zou, Y., Xiong, H., Xiong, H., Lu, T., Zhu, F., Luo, Z., et al. A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice. Tumour Biol 36:4 (2015), 2929–2936.
24. [24] Wang, J., Zhu, C.P., Hu, P.F., Qian, H., Ning, B.F., Zhang, Q., et al. FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition. Carcinogenesis 35 (2014), 2576–2583.
25. [25] Wang, N., Zhu, M., Tsao, S.W., Man, K., Zhang, Z., Feng, Y., Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma. PLoS One, 7, 2012, e46318.
26. [26] Daniele, A., Divella, R., Quaranta, M., Mattioli, V., Casamassima, P., Paradiso, A., et al. Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization. Clin Biochem 47 (2014), 184–190.